secwatch.observer — SEC 8-K summary
======================================

Issuer:     Akari Therapeutics Plc (AKTX)
CIK:        0001541157
Form:       8-K
Filed at:   2024-03-11T23:59:59+00:00
Accession:  0001104659-24-033087
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Akari Therapeutics raises ~$1.615M in private placement of ADSs for working capital
--------------------------------------------------------------------------------

- Pricing at lower of $1.57 or 0.7× 15-day VWAP, floor $1.12 per ADS, each ADS representing 2,000 ordinary shares.
- Private placement expected to close on or about March 21, 2024, subject to customary conditions.
- Placement agent Paulson Investment to receive 10% cash fee and warrants exercisable at 125% of offering price for 5 years.
- Company agreed to file registration statement for resale of the ADSs by March 31, 2024.
- Exchange cap of 1,320,616 ADSs (19.99% of outstanding ordinary shares) unless shareholder approval obtained.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1541157/000110465924033087/0001104659-24-033087-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1541157/000110465924033087/tm248477d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-033087

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer